Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

LifeStance Health (LFST) Gains from Investment Securities (2021 - 2025)

LifeStance Health (LFST) has disclosed Gains from Investment Securities for 5 consecutive years, with $7.1 million as the latest value for Q4 2025.

  • On a quarterly basis, Gains from Investment Securities changed N/A to $7.1 million in Q4 2025 year-over-year; TTM through Dec 2025 was $7.9 million, a N/A change, with the full-year FY2025 number at $8.7 million, down 35.4% from a year prior.
  • Gains from Investment Securities was $7.1 million for Q4 2025 at LifeStance Health, up from $609000.0 in the prior quarter.
  • In the past five years, Gains from Investment Securities ranged from a high of $7.1 million in Q4 2025 to a low of -$416000.0 in Q4 2023.
  • A 5-year average of $636933.3 and a median of $103000.0 in 2023 define the central range for Gains from Investment Securities.
  • Peak YoY movement for Gains from Investment Securities: crashed 2100.0% in 2022, then soared 341.67% in 2025.
  • LifeStance Health's Gains from Investment Securities stood at $1.4 million in 2021, then crashed by 108.0% to -$115000.0 in 2022, then tumbled by 261.74% to -$416000.0 in 2023, then soared by 137.02% to $154000.0 in 2024, then skyrocketed by 4537.01% to $7.1 million in 2025.
  • Per Business Quant, the three most recent readings for LFST's Gains from Investment Securities are $7.1 million (Q4 2025), $609000.0 (Q1 2025), and $154000.0 (Q3 2024).